Akanda (AKAN) Stock Price, News & Analysis

Company Overview

Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.

Key Stats

• Today's Range: $8.06 to $8.46
• 50-Day Range: $7.96 to $27.12
• 52-Week Range: $2.30 to $209.02
• Volume: 4,216 shs
• Average Volume: 1.18 million shs
• Market Capitalization: $4.46 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Akanda Stock Analysis - MarketRank™

Akanda scored higher than 15% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

Akanda has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Akanda has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: N/A
• Proj. Earnings Growth: N/A

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.22% of the float of Akanda has been sold short.

Short Interest Ratio / Days to Cover

Akanda has a short interest ratio ("days to cover") of 0.41, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Akanda has recently decreased by 87.00%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Akanda does not currently pay a dividend.

Dividend Growth

Akanda does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

Search Interest

Only 1 people have searched for AKAN on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Akanda insiders have not sold or bought any company stock.

Percentage Held by Insiders

20.39% of the stock of Akanda is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

1.00% of the stock of Akanda is held by institutions.

Company Calendar

• Last Earnings: 6/09/2026
• Today: 7/23/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Pharmaceutical Products
• Current Symbol: NASDAQ:AKAN
• CIK: 1888014
• Web: www.akandacorp.com
• Phone: 44-20-3488-9514
• Fax: N/A
• Employees: 110
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.58
• Quick Ratio: 0.58

Sales & Book Value

• Annual Sales: $260 thousand
• Price / Sales: 17.15
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($25.68) per share
• Price / Book: -0.32

Miscellaneous

• Outstanding Shares: 540,000
• Free Float: 431,000
• Market Cap: $4.46 million
• Optionable: Not Optionable
• Beta: 14.06